Advisornet Financial’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-177
Closed -$44K 2027
2021
Q3
$44K Hold
177
﹤0.01% 1039
2021
Q2
$73K Sell
177
-50
-22% -$19.8K ﹤0.01% 874
2021
Q1
$89K Buy
227
+142
+167% +$69.9K 0.01% 786
2020
Q4
$48K Buy
85
+23
+37% +$14.6K ﹤0.01% 881
2020
Q3
$43K Hold
62
﹤0.01% 889
2020
Q2
$49K Hold
62
﹤0.01% 862
2020
Q1
$37K Hold
62
﹤0.01% 892
2019
Q4
$70K Hold
62
0.01% 786
2019
Q3
$73K Hold
62
0.01% 774
2019
Q2
$102K Hold
62
0.01% 606
2019
Q1
$126K Hold
62
0.02% 501
2018
Q4
$79K Hold
62
0.01% 576
2018
Q3
$117K Hold
62
0.01% 520
2018
Q2
$126K Hold
62
0.02% 473
2018
Q1
$137K Hold
62
0.02% 468
2017
Q4
$142K Buy
+62
New +$126K 0.02% 410

Other funds holding BLUE

Advisornet Financial's BLUE Position: Q4 2021 in Review

Advisornet Financial sold out of bluebird bio (BLUE) in Q4 2021, closing a stake of 177 shares — an estimated $44K sold.

Advisornet Financial first reported a position in BLUE in Q4 2017 and held it in 16 quarters. The position peaked at $142K in Q4 2017. 172 funds tracked by Wall St. Rank hold BLUE as of Q4 2021.

  • Advisornet Financial reported no remaining bluebird bio position as of Q4 2021 after selling out during the quarter.
  • Advisornet Financial sold 177 bluebird bio shares in Q4 2021, an estimated $44K.
  • Advisornet Financial first reported a position in bluebird bio in Q4 2017 and held it in 16 quarters.
  • Advisornet Financial's bluebird bio position peaked at $142K in Q4 2017.
  • 172 funds tracked by Wall St. Rank held bluebird bio as of Q4 2021.

Based on Advisornet Financial's 13F filing for Q4 2021, filed 19 Jan 2022.